Oscar Health, Inc. 三季度每股亏损为0.53美元，好于分析师预期的每股亏损 0.56 美元。营收达到 29.9 亿美元，同比增长 23%，高于去年同期的 24.2 亿美元，但低于市场普遍预期的 30.8 亿美元。
截至2025年9月30日，Oscar Health的会员总数增至212万，高于上年同期的165万。公司销售、管理及行政费用率从上年同期的19.0%降至17.5%，这反映出公司提高了固定成本杠杆率并加强了成本控制。
Oscar Health预计2025年全年总营收将在120亿美元至122亿美元之间，而FactSet此前预测为120.1亿美元。公司预计将于2026年恢复盈利。
Oscar Health还宣布部分偿还其2031年到期的可转换优先票据，约1.875亿美元兑换成约2330万股A类普通股。
Oscar Health首席执行官马克·贝托利尼表示：“Oscar正以经济实惠、创新的计划和卓越的会员体验，引领个人医疗保健的未来。”
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.